247 related articles for article (PubMed ID: 10780879)
21. Malignant soft tissue tumors in children.
Thacker MM
Orthop Clin North Am; 2013 Oct; 44(4):657-67. PubMed ID: 24095080
[TBL] [Abstract][Full Text] [Related]
22. Noncanonical roles of p53 in cancer stemness and their implications in sarcomas.
Curylova L; Ramos H; Saraiva L; Skoda J
Cancer Lett; 2022 Jan; 525():131-145. PubMed ID: 34742870
[TBL] [Abstract][Full Text] [Related]
23. [The results of limb-sparing multimodal therapy in soft-tissue sarcomas in adulthood].
Budach V
Strahlenther Onkol; 1996 Aug; 172(8):461-3. PubMed ID: 8765351
[No Abstract] [Full Text] [Related]
24. [Not Available].
Blay JY
Bull Acad Natl Med; 2015 Jan; 199(1):41-60; discussion 60-1. PubMed ID: 27236877
[No Abstract] [Full Text] [Related]
25. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ
Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343
[TBL] [Abstract][Full Text] [Related]
26. [Immunologic presentation of P53 protein in cell nucleus of soft tissue sarcoma].
Budach V
Strahlenther Onkol; 1995 Jan; 171(1):55-6. PubMed ID: 7839308
[No Abstract] [Full Text] [Related]
27. Soft tissue sarcoma in adults.
Mertens WC; Bramwell VH
Curr Opin Oncol; 1993 Jul; 5(4):678-84. PubMed ID: 8364085
[TBL] [Abstract][Full Text] [Related]
28. Genetics of soft tissue tumors.
van de Rijn M; Fletcher JA
Annu Rev Pathol; 2006; 1():435-66. PubMed ID: 18039122
[TBL] [Abstract][Full Text] [Related]
29. [Soft tissue sarcomas: clinical application of molecular biology].
Chetaille B; Laibe S; Choukeir N; Bertucci F
Rev Prat; 2013 Mar; 63(3):309-13. PubMed ID: 23687749
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetics of soft tissue sarcomas.
Cooper CS; Cornes P
Cancer Treat Res; 1997; 91():31-50. PubMed ID: 9286487
[No Abstract] [Full Text] [Related]
31. Pediatric undifferentiated sarcoma of the soft tissues: a clinicopathologic study.
Somers GR; Gupta AA; Doria AS; Ho M; Pereira C; Shago M; Thorner PS; Zielenska M
Pediatr Dev Pathol; 2006; 9(2):132-42. PubMed ID: 16822084
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in soft-tissue sarcomas: what have we learnt?
Choong PF; Rüdiger HA
Expert Rev Anticancer Ther; 2008 Feb; 8(2):139-46. PubMed ID: 18279053
[No Abstract] [Full Text] [Related]
33. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
[TBL] [Abstract][Full Text] [Related]
34. Soft tissue sarcomas: research of prognostic factors and therapeutics scheme.
Montagnese A; Sturla M; Bruno I; Bracaglia R; Salgarello M; Seccia A; Farallo E
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):219-22. PubMed ID: 16767935
[TBL] [Abstract][Full Text] [Related]
35. Preoperative therapy for soft tissue sarcoma.
Eilber F; Eckardt J; Rosen G; Forscher C; Selch M; Fu YS
Hematol Oncol Clin North Am; 1995 Aug; 9(4):817-23. PubMed ID: 7490243
[TBL] [Abstract][Full Text] [Related]
36. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
38. Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells.
Pollock RE; Lang A; Luo J; El-Naggar AK; Yu D
Oncogene; 1996 May; 12(9):2035-9. PubMed ID: 8649865
[TBL] [Abstract][Full Text] [Related]
39. Emerging perspectives in soft tissue sarcoma. Preface.
Pollock RE
Surg Oncol Clin N Am; 2003 Apr; 12(2):xiii-xiv. PubMed ID: 12916455
[No Abstract] [Full Text] [Related]
40. [p53 overexpression as independent prognostic marker in soft tissue sarcomas is antibody dependent].
Würl P; Taubert H; Meye A; Berger D; Holzhausen HJ; Schmidt H; Hinze R; Rath FW; Schönfelder M
Verh Dtsch Ges Pathol; 1998; 82():358-61. PubMed ID: 10095460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
